TY - JOUR AU - Chiocca, E. A. PY - 2002 DA - 2002// TI - Oncolytic viruses JO - Nat Rev Cancer VL - 2 UR - https://doi.org/10.1038/nrc948 DO - 10.1038/nrc948 ID - Chiocca2002 ER - TY - CHAP AU - Kirn, D. PY - 2003 DA - 2003// TI - Oncolytic virotherapy as a novel treatment platform for cancer BT - Ernst Schering Res Found Workshop ID - Kirn2003 ER - TY - JOUR AU - Nemunaitis, J. AU - Edelman, J. PY - 2002 DA - 2002// TI - Selectively replicating viral vectors JO - Cancer Gene Ther VL - 9 UR - https://doi.org/10.1038/sj.cgt.7700547 DO - 10.1038/sj.cgt.7700547 ID - Nemunaitis2002 ER - TY - JOUR AU - Nemunaitis, J. PY - 2002 DA - 2002// TI - Live viruses in cancer treatment JO - Oncology (Williston Park) VL - 16 ID - Nemunaitis2002 ER - TY - JOUR AU - Lachmann, R. PY - 2004 DA - 2004// TI - Herpes simplex virus-based vectors JO - Int J Exp Pathol VL - 85 UR - https://doi.org/10.1111/j.0959-9673.2004.00383.x DO - 10.1111/j.0959-9673.2004.00383.x ID - Lachmann2004 ER - TY - JOUR AU - Fu, X. AU - Nakamori, M. AU - Tao, L. AU - Amato, R. AU - Zhang, X. PY - 2007 DA - 2007// TI - Antitumor effects of two newly constructed oncolytic herpes simplex viruses against renal cell carcinoma JO - Int J Oncol VL - 30 ID - Fu2007 ER - TY - JOUR AU - Fu, X. AU - Tao, L. AU - Cai, R. AU - Prigge, J. AU - Zhang, X. PY - 2006 DA - 2006// TI - A mutant type 2 herpes simplex virus deleted for the protein kinase domain of the ICP10 gene is a potent oncolytic virus JO - Mol Ther VL - 13 UR - https://doi.org/10.1016/j.ymthe.2006.02.007 DO - 10.1016/j.ymthe.2006.02.007 ID - Fu2006 ER - TY - JOUR AU - Meseda, C. A. AU - Schmeisser, F. AU - Pedersen, R. AU - Woerner, A. AU - Weir, J. P. PY - 2004 DA - 2004// TI - DNA immunization with a herpes simplex virus 2 bacterial artificial chromosome JO - Virology VL - 318 UR - https://doi.org/10.1016/j.virol.2003.09.033 DO - 10.1016/j.virol.2003.09.033 ID - Meseda2004 ER - TY - JOUR AU - Schmeisser, F. AU - Weir, J. P. PY - 2007 DA - 2007// TI - Incorporation of a lambda phage recombination system and EGFP detection to simplify mutagenesis of Herpes simplex virus bacterial artificial chromosomes JO - BMC Biotechnol VL - 7 UR - https://doi.org/10.1186/1472-6750-7-22 DO - 10.1186/1472-6750-7-22 ID - Schmeisser2007 ER - TY - JOUR AU - Jeyaretna, D. S. AU - Kuroda, T. PY - 2007 DA - 2007// TI - Recent advances in the development of oncolytic HSV-1 vectors: 'arming' of HSV-1 vectors and application of bacterial artificial chromosome technology for their construction JO - Curr Opin Mol Ther VL - 9 ID - Jeyaretna2007 ER - TY - JOUR AU - Thomas, D. L. AU - Fraser, N. W. PY - 2003 DA - 2003// TI - HSV-1 therapy of primary tumors reduces the number of metastases in an immune-competent model of metastatic breast cancer JO - Mol Ther VL - 8 UR - https://doi.org/10.1016/S1525-0016(03)00236-3 DO - 10.1016/S1525-0016(03)00236-3 ID - Thomas2003 ER - TY - JOUR AU - Todo, T. AU - Rabkin, S. D. AU - Sundaresan, P. AU - Wu, A. AU - Meehan, K. R. AU - Herscowitz, H. B. AU - Martuza, R. L. PY - 1999 DA - 1999// TI - Systemic antitumor immunity in experimental brain tumor therapy using a multimutated, replication-competent herpes simplex virus JO - Hum Gene Ther VL - 10 UR - https://doi.org/10.1089/10430349950016483 DO - 10.1089/10430349950016483 ID - Todo1999 ER - TY - JOUR AU - Miller, C. G. AU - Fraser, N. W. PY - 2003 DA - 2003// TI - Requirement of an integrated immune response for successful neuroattenuated HSV-1 therapy in an intracranial metastatic melanoma model JO - Mol Ther VL - 7 UR - https://doi.org/10.1016/S1525-0016(03)00120-5 DO - 10.1016/S1525-0016(03)00120-5 ID - Miller2003 ER - TY - JOUR AU - Nakamori, M. AU - Fu, X. AU - Rousseau, R. AU - Chen, S. Y. AU - Zhang, X. PY - 2004 DA - 2004// TI - Destruction of nonimmunogenic mammary tumor cells by a fusogenic oncolytic herpes simplex virus induces potent antitumor immunity JO - Mol Ther VL - 9 UR - https://doi.org/10.1016/j.ymthe.2004.02.019 DO - 10.1016/j.ymthe.2004.02.019 ID - Nakamori2004 ER - TY - JOUR AU - Li, H. AU - Dutuor, A. AU - Fu, X. AU - Zhang, X. PY - 2007 DA - 2007// TI - Induction of strong antitumor immunity by an HSV-2-based oncolytic virus in a murine mammary tumor model JO - J Gene Med VL - 9 UR - https://doi.org/10.1002/jgm.1005 DO - 10.1002/jgm.1005 ID - Li2007 ER - TY - JOUR AU - Hoffmann, D. AU - Bayer, W. AU - Wildner, O. PY - 2007 DA - 2007// TI - Local and distant immune-mediated control of colon cancer growth with fusogenic membrane glycoproteins in combination with viral oncolysis JO - Hum Gene Ther VL - 18 UR - https://doi.org/10.1089/hum.2006.185 DO - 10.1089/hum.2006.185 ID - Hoffmann2007 ER - TY - JOUR AU - Kemeny, N. AU - Brown, K. AU - Covey, A. AU - Kim, T. AU - Bhargava, A. AU - Brody, L. AU - Guilfoyle, B. AU - Haag, N. P. AU - Karrasch, M. AU - Glasschroeder, B. PY - 2006 DA - 2006// TI - Phase I, Open-Label, Dose-Escalating Study of a Genetically Engineered Herpes Simplex Virus, NV1020, in Subjects with Metastatic Colorectal Carcinoma to the Liver JO - Hum Gene Ther VL - 17 UR - https://doi.org/10.1089/hum.2006.17.1214 DO - 10.1089/hum.2006.17.1214 ID - Kemeny2006 ER - TY - JOUR AU - Miller, C. G. AU - Fraser, N. W. PY - 2000 DA - 2000// TI - Role of the immune response during neuro-attenuated herpes simplex virus-mediated tumor destruction in a murine intracranial melanoma model JO - Cancer Res VL - 60 ID - Miller2000 ER - TY - JOUR AU - Cozzi, P. J. AU - Burke, P. B. AU - Bhargav, A. AU - Heston, W. D. AU - Huryk, B. AU - Scardino, P. T. AU - Fong, Y. PY - 2002 DA - 2002// TI - Oncolytic viral gene therapy for prostate cancer using two attenuated, replication-competent, genetically engineered herpes simplex viruses JO - Prostate VL - 53 UR - https://doi.org/10.1002/pros.10138 DO - 10.1002/pros.10138 ID - Cozzi2002 ER - TY - JOUR AU - Cozzi, P. J. AU - Malhotra, S. AU - McAuliffe, P. AU - Kooby, D. A. AU - Federoff, H. J. AU - Huryk, B. AU - Johnson, P. AU - Scardino, P. T. AU - Heston, W. D. AU - Fong, Y. PY - 2001 DA - 2001// TI - Intravesical oncolytic viral therapy using attenuated, replication-competent herpes simplex viruses G207 and Nv1020 is effective in the treatment of bladder cancer in an orthotopic syngeneic model JO - Faseb J VL - 15 ID - Cozzi2001 ER - TY - JOUR AU - Gutermann, A. AU - Mayer, E. AU - Von Dehn-Rothfelser, K. AU - Breidenstein, C. AU - Weber, M. AU - Muench, M. AU - Gungor, D. AU - Suehnel, J. AU - Moebius, U. AU - Lechmann, M. PY - 2006 DA - 2006// TI - Efficacy of oncolytic herpesvirus NV1020 can be enhanced by combination with chemotherapeutics in colon carcinoma cells JO - Hum Gene Ther VL - 17 UR - https://doi.org/10.1089/hum.2006.17.1241 DO - 10.1089/hum.2006.17.1241 ID - Gutermann2006 ER - TY - JOUR AU - McAuliffe, P. F. AU - Jarnagin, W. R. AU - Johnson, P. AU - Delman, K. A. AU - Federoff, H. AU - Fong, Y. PY - 2000 DA - 2000// TI - Effective treatment of pancreatic tumors with two multimutated herpes simplex oncolytic viruses JO - J Gastrointest Surg VL - 4 UR - https://doi.org/10.1016/S1091-255X(00)80106-7 DO - 10.1016/S1091-255X(00)80106-7 ID - McAuliffe2000 ER - TY - JOUR AU - Advani, S. J. AU - Chung, S. M. AU - Yan, S. Y. AU - Gillespie, G. Y. AU - Markert, J. M. AU - Whitley, R. J. AU - Roizman, B. AU - Weichselbaum, R. R. PY - 1999 DA - 1999// TI - Replication-competent, nonneuroinvasive genetically engineered herpes virus is highly effective in the treatment of therapy-resistant experimental human tumors JO - Cancer Res VL - 59 ID - Advani1999 ER - TY - JOUR AU - Meignier, B. AU - Longnecker, R. AU - Roizman, B. PY - 1988 DA - 1988// TI - In vivo behavior of genetically engineered herpes simplex viruses R7017 and R7020: construction and evaluation in rodents JO - J Infect Dis VL - 158 UR - https://doi.org/10.1093/infdis/158.3.602 DO - 10.1093/infdis/158.3.602 ID - Meignier1988 ER - TY - JOUR AU - Meignier, B. AU - Martin, B. AU - Whitley, R. J. AU - Roizman, B. PY - 1990 DA - 1990// TI - In vivo behavior of genetically engineered herpes simplex viruses R7017 and R7020. II. Studies in immunocompetent and immunosuppressed owl monkeys (Aotus trivirgatus) JO - J Infect Dis VL - 162 UR - https://doi.org/10.1093/infdis/162.2.313 DO - 10.1093/infdis/162.2.313 ID - Meignier1990 ER - TY - CHAP AU - Cadoz, M. AU - Seigneurin, J. M. AU - Mallaret, M. R. AU - Baccard, C. AU - Morand, P. PY - 1992 DA - 1992// TI - Phase I trial of R7020: A live attenuated recombinant herpes simplex virus (HSV) candidate vaccine BT - Program and Abstacts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy PB - American Society of Microbiology, Washington, D.C CY - Washington, D.C ID - Cadoz1992 ER - TY - JOUR AU - Chou, J. AU - Kern, E. R. AU - Whitley, R. J. AU - Roizman, B. PY - 1990 DA - 1990// TI - Mapping of herpes simplex virus-1 neurovirulence to gamma 134.5, a gene nonessential for growth in culture JO - Science VL - 250 UR - https://doi.org/10.1126/science.2173860 DO - 10.1126/science.2173860 ID - Chou1990 ER - TY - JOUR AU - Chou, J. AU - Roizman, B. PY - 1992 DA - 1992// TI - The gamma 1(34.5) gene of herpes simplex virus 1 precludes neuroblastoma cells from triggering total shutoff of protein synthesis characteristic of programed cell death in neuronal cells JO - Proc Natl Acad Sci USA VL - 89 UR - https://doi.org/10.1073/pnas.89.8.3266 DO - 10.1073/pnas.89.8.3266 ID - Chou1992 ER - TY - JOUR AU - Kramm, C. M. AU - Chase, M. AU - Herrlinger, U. AU - Jacobs, A. AU - Pechan, P. A. AU - Rainov, N. G. AU - Sena-Esteves, M. AU - Aghi, M. AU - Barnett, F. H. AU - Chiocca, E. A. AU - Breakefield, X. O. PY - 1997 DA - 1997// TI - Therapeutic efficiency and safety of a second-generation replication-conditional HSV1 vector for brain tumor gene therapy JO - Hum Gene Ther VL - 8 UR - https://doi.org/10.1089/hum.1997.8.17-2057 DO - 10.1089/hum.1997.8.17-2057 ID - Kramm1997 ER - TY - JOUR AU - Bzik, D. J. AU - Fox, B. A. AU - DeLuca, N. A. AU - Person, S. PY - 1984 DA - 1984// TI - Nucleotide sequence specifying the glycoprotein gene, gB, of herpes simplex virus type 1 JO - Virology VL - 133 UR - https://doi.org/10.1016/0042-6822(84)90397-0 DO - 10.1016/0042-6822(84)90397-0 ID - Bzik1984 ER - TY - JOUR AU - Pellett, P. E. AU - Kousoulas, K. G. AU - Pereira, L. AU - Roizman, B. PY - 1985 DA - 1985// TI - Anatomy of the herpes simplex virus 1 strain F glycoprotein B gene: primary sequence and predicted protein structure of the wild type and of monoclonal antibody-resistant mutants JO - J Virol VL - 53 ID - Pellett1985 ER - TY - JOUR AU - Bzik, D. J. AU - Fox, B. A. AU - DeLuca, N. A. AU - Person, S. PY - 1984 DA - 1984// TI - Nucleotide sequence of a region of the herpes simplex virus type 1 gB glycoprotein gene: mutations affecting rate of virus entry and cell fusion JO - Virology VL - 137 UR - https://doi.org/10.1016/0042-6822(84)90022-9 DO - 10.1016/0042-6822(84)90022-9 ID - Bzik1984 ER - TY - JOUR AU - Bond, V. C. AU - Person, S. PY - 1984 DA - 1984// TI - Fine structure physical map locations of alterations that affect cell fusion in herpes simplex virus type 1 JO - Virology VL - 132 UR - https://doi.org/10.1016/0042-6822(84)90042-4 DO - 10.1016/0042-6822(84)90042-4 ID - Bond1984 ER - TY - JOUR AU - Debroy, C. AU - Pederson, N. AU - Person, S. PY - 1985 DA - 1985// TI - Nucleotide sequence of a herpes simplex virus type 1 gene that causes cell fusion JO - Virology VL - 145 UR - https://doi.org/10.1016/0042-6822(85)90199-0 DO - 10.1016/0042-6822(85)90199-0 ID - Debroy1985 ER - TY - CHAP AU - Foster, T. P. AU - Chouljenko, V. N. AU - Kousoulas, K. G. PY - 2008 DA - 2008// TI - Functional and Physical Interactions of the Herpes Simplex Virus Type-1 (HSV-1) UL20 Membrane Protein with Glycoprotein K (gK) BT - J Virol ID - Foster2008 ER - TY - JOUR AU - Foster, T. P. AU - Melancon, J. M. AU - Olivier, T. L. AU - Kousoulas, K. G. PY - 2004 DA - 2004// TI - Herpes simplex virus type 1 glycoprotein K and the UL20 protein are interdependent for intracellular trafficking and trans-Golgi network localization JO - J Virol VL - 78 UR - https://doi.org/10.1128/JVI.78.23.13262-13277.2004 DO - 10.1128/JVI.78.23.13262-13277.2004 ID - Foster2004 ER - TY - JOUR AU - Israyelyan, A. H. AU - Melancon, J. M. AU - Lomax, L. G. AU - Sehgal, I. AU - Leuschner, C. AU - Kearney, M. T. AU - Chouljenko, V. N. AU - Baghian, A. AU - Kousoulas, K. G. PY - 2007 DA - 2007// TI - Effective treatment of human breast tumor in a mouse xenograft model with herpes simplex virus type 1 specifying the NV1020 genomic deletion and the gBsyn3 syncytial mutation enabling high viral replication and spread in breast cancer cells JO - Hum Gene Ther VL - 18 UR - https://doi.org/10.1089/hum.2006.145 DO - 10.1089/hum.2006.145 ID - Israyelyan2007 ER - TY - JOUR AU - Manservigi, R. AU - Spear, P. G. AU - Buchan, A. PY - 1977 DA - 1977// TI - Cell fusion induced by herpes simplex virus is promoted and suppressed by different viral glycoproteins JO - Proc Natl Acad Sci USA VL - 74 UR - https://doi.org/10.1073/pnas.74.9.3913 DO - 10.1073/pnas.74.9.3913 ID - Manservigi1977 ER - TY - JOUR AU - Tischer, B. K. AU - von Einem, J. AU - Kaufer, B. AU - Osterrieder, N. PY - 2006 DA - 2006// TI - Two-step red-mediated recombination for versatile high-efficiency markerless DNA manipulation in Escherichia coli JO - Biotechniques VL - 40 UR - https://doi.org/10.2144/000112096 DO - 10.2144/000112096 ID - Tischer2006 ER - TY - JOUR AU - Aslakson, C. J. AU - Miller, F. R. PY - 1992 DA - 1992// TI - Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor JO - Cancer Res VL - 52 ID - Aslakson1992 ER - TY - JOUR AU - Kastrukoff, L. F. AU - Lau, A. S. AU - Puterman, M. L. PY - 1986 DA - 1986// TI - Genetics of natural resistance to herpes simplex virus type 1 latent infection of the peripheral nervous system in mice JO - J Gen Virol VL - 67 UR - https://doi.org/10.1099/0022-1317-67-4-613 DO - 10.1099/0022-1317-67-4-613 ID - Kastrukoff1986 ER - TY - JOUR AU - Lopez, C. PY - 1975 DA - 1975// TI - Genetics of natural resistance to herpesvirus infections in mice JO - Nature VL - 258 UR - https://doi.org/10.1038/258152a0 DO - 10.1038/258152a0 ID - Lopez1975 ER - TY - JOUR AU - Shukla, D. AU - Dal Canto, M. C. AU - Rowe, C. L. AU - Spear, P. G. PY - 2000 DA - 2000// TI - Striking similarity of murine nectin-1alpha to human nectin-1alpha (HveC) in sequence and activity as a glycoprotein D receptor for alphaherpesvirus entry JO - J Virol VL - 74 UR - https://doi.org/10.1128/JVI.74.24.11773-11781.2000 DO - 10.1128/JVI.74.24.11773-11781.2000 ID - Shukla2000 ER - TY - JOUR AU - Even, D. L. AU - Henley, A. M. AU - Geraghty, R. J. PY - 2006 DA - 2006// TI - The requirements for herpes simplex virus type 1 cell-cell spread via nectin-1 parallel those for virus entry JO - Virus Res VL - 119 UR - https://doi.org/10.1016/j.virusres.2006.01.012 DO - 10.1016/j.virusres.2006.01.012 ID - Even2006 ER - TY - CHAP AU - Reif, A. E. ED - Reif, A. E. ED - Mitchell, E. M. S. PY - 1985 DA - 1985// TI - Some key problems for success of classical immunotherapy BT - Immunity to Cancer PB - Academic Press CY - New York ID - Reif1985 ER - TY - CHAP AU - Miller, F. R. ED - Dickson, M. E. L. R. B. PY - 1996 DA - 1996// TI - Models of progression spanning preneoplasia and metastasis: the human MCF10neoT.Tgn series and a panel of mouse mammary tumors subpopulations BT - Mammary tumor cell cycle, Differentiation, and Metastasis PB - Kluwer Academic CY - Boston UR - https://doi.org/10.1007/978-1-4613-1259-8_13 DO - 10.1007/978-1-4613-1259-8_13 ID - Miller1996 ER - TY - JOUR AU - Pulaski, B. A. AU - Ostrand-Rosenberg, S. PY - 1998 DA - 1998// TI - Reduction of established spontaneous mammary carcinoma metastases following immunotherapy with major histocompatibility complex class II and B7.1 cell-based tumor vaccines JO - Cancer Res VL - 58 ID - Pulaski1998 ER - TY - JOUR AU - Foster, T. P. AU - Alvarez, X. AU - Kousoulas, K. G. PY - 2003 DA - 2003// TI - Plasma membrane topology of syncytial domains of herpes simplex virus type 1 glycoprotein K (gK): the UL20 protein enables cell surface localization of gK but not gK-mediated cell-to-cell fusion JO - J Virol VL - 77 UR - https://doi.org/10.1128/JVI.77.1.499-510.2003 DO - 10.1128/JVI.77.1.499-510.2003 ID - Foster2003 ER - TY - JOUR AU - Foster, T. P. AU - Rybachuk, G. V. AU - Kousoulas, K. G. PY - 2001 DA - 2001// TI - Glycoprotein K specified by herpes simplex virus type 1 is expressed on virions as a Golgi complex-dependent glycosylated species and functions in virion entry JO - J Virol VL - 75 UR - https://doi.org/10.1128/JVI.75.24.12431-12438.2001 DO - 10.1128/JVI.75.24.12431-12438.2001 ID - Foster2001 ER -